English

Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from […]

Study reveals 75 percent of the world’s industrial fishing vessels are hidden from public view WASHINGTON, D.C., Jan. 03, 2024 (GLOBE NEWSWIRE) — A new study published today in the journal Nature offers an unprecedented view of previously unmapped industrial use of the ocean and how it is changing. The groundbreaking study, led by Global Fishing Watch, uses […]

WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology growth company, today announced that it closed the acquisition of LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions. Lima strengthens Enovis’ position in the global orthopedic reconstruction […]

Foothill Ranch, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Sweegen, the global leader in pioneering wellness ingredient and taste modulation technologies, announced a landmark victory in the U.S. Court of Appeals for the Federal Circuit, which has sided with Sweegen and affirmed the invalidation of PureCircle’s patents covering the highly sought-after stevia sweetener Rebaudioside M […]

FMF strengthens the Kingdom’s leadership in enabling the Super Region to contribute to the metals industries of the future RIYADH, Saudi Arabia, Jan. 02, 2024 (GLOBE NEWSWIRE) — The Future Minerals Forum (FMF) announced today that its Ministerial Roundtable, due to be held on 9 January 2024, ahead of the third edition of the Forum, […]

NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of National Instruments Corporation (NASDAQ: NATI) between May 25, 2022 and January 17, 2023, both dates inclusive (the “Class Period”), of the important January 29, 2024 lead plaintiff deadline. SO WHAT: If […]

NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Li-Cycle Holdings Corp. (NYSE: LICY) between June 14, 2022 and October 23, 2023, both dates inclusive (the “Class Period”), of the important January 8, 2024 lead plaintiff deadline. SO WHAT: If you […]